Security Snapshot

GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) Institutional Ownership

CUSIP: G3855L106

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

53

Shares (Excl. Options)

46,564,278

Price

$12.70

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Ordinary Shares, nominal value $0.025 per share
Symbol
GHRS on Nasdaq
Shares outstanding
61,943,899
Price per share
$15.27
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
46,564,278
Total reported value
$591,366,552
% of total 13F portfolios
0%
Share change
+1,743,447
Value change
+$19,014,477
Number of holders
53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share is tracked under CUSIP G3855L106.
  • 53 institutions reported positions in Q4 2025.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 53 to 13 between Q4 2025 and Q1 2026.
  • Reported value moved from $591,366,552 to $171,640,186.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 53 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP G3855L106?
CUSIP G3855L106 identifies GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 17% +21% $164,840,148 +$28,597,314 10,406,575 +21% Lynx1 Capital Management LP 31 Dec 2025
BIOTECHNOLOGY VALUE FUND L P 14% $84,128,095 8,827,712 BVF PARTNERS L P/IL 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 12% +11% $123,210,987 +$11,749,386 7,676,697 +11% RA Capital Management, L.P. 30 Jun 2025
RTW INVESTMENTS, LP 8.9% $52,412,799 5,499,769 RTW Investments, LP 31 Mar 2025
FMR LLC 8.2% +19% $81,728,927 +$13,523,168 5,092,145 +20% FMR LLC 30 Jun 2025
Terwey Theis H 2.9% -59% $25,515,004 -$41,593,509 1,784,266 -62% Terwey Theis H 30 Sep 2025

As of 31 Dec 2025, 53 institutional investors reported holding 46,564,278 shares of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS). This represents 75% of the company’s total 61,943,899 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lynx1 Capital Management LP 17% 10,406,575 +21% 27% $132,163,502
BVF INC/IL 14% 8,827,712 0% 3.8% $112,111,942
RA CAPITAL MANAGEMENT, L.P. 12% 7,676,697 0% 1% $97,494,052
RTW INVESTMENTS, LP 9.6% 5,933,815 +6.5% 0.75% $75,359,451
FMR LLC 8.3% 5,136,045 -3.6% 0% $65,227,771
Avoro Capital Advisors LLC 2.9% 1,800,000 0.22% $22,860,000
Cormorant Asset Management, LP 2.1% 1,300,000 -32% 0.94% $16,510,000
Jefferies Financial Group Inc. 1.1% 712,300 +0.42% 0.07% $9,046,210
Verition Fund Management LLC 1.1% 673,735 -0.7% 0.05% $8,556,435
5AM Venture Management, LLC 0.92% 572,665 0% 2.3% $7,272,846
BlackRock, Inc. 0.7% 434,401 +651% 0% $5,516,893
Troluce Capital Advisors LLC 0.6% 373,212 +699% 3.5% $4,739,792
UBS Group AG 0.59% 363,381 -29% 0% $4,614,939
Squadron Capital Management LLC 0.51% 315,000 0% 1.8% $4,000,500
MILLENNIUM MANAGEMENT LLC 0.48% 295,926 -66% 0% $3,758,260
CenterBook Partners LP 0.46% 283,441 +71% 0.18% $3,599,701
MARSHALL WACE, LLP 0.39% 240,764 +42% 0% $3,057,703
HighVista Strategies LLC 0.39% 240,524 -0.57% 0.79% $3,054,655
Alyeska Investment Group, L.P. 0.33% 204,975 0% 0.01% $2,603,183
BOOTHBAY FUND MANAGEMENT, LLC 0.18% 112,184 +34% 0.04% $1,424,737
GOLDMAN SACHS GROUP INC 0.13% 80,986 +631% 0% $1,028,522
AdvisorShares Investments LLC 0.11% 67,112 +24% 0.14% $852,322
Trexquant Investment LP 0.09% 54,776 0.01% $695,655
MORGAN STANLEY 0.08% 51,404 +1112% 0% $652,830
JANE STREET GROUP, LLC 0.08% 50,005 +117% 0% $635,063

Institutional Holders of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 12,207,690 $171,640,186 +$4,613,669 $14.06 13
2025 Q4 46,564,278 $591,366,552 +$19,014,477 $12.70 53
2025 Q3 44,533,428 $618,134,274 +$14,411,795 $14.30 47
2025 Q2 43,554,151 $530,925,463 +$12,435,267 $12.19 37
2025 Q1 42,619,365 $470,078,472 +$132,646,472 $11.03 35
2024 Q4 30,702,522 $214,921,353 +$703,147 $7.00 31
2024 Q3 30,520,551 $204,184,484 +$470,359 $6.69 28
2024 Q2 30,425,860 $354,768,061 +$9,911,656 $11.66 28
2024 Q1 29,598,383 $315,521,410 +$9,696,487 $10.66 32
2023 Q4 29,604,263 $171,708,593 +$1,756,706 $5.80 35
2023 Q3 29,004,299 $291,487,763 -$8,205,765 $10.05 29
2023 Q2 29,634,294 $351,618,806 -$693,689 $11.86 34
2023 Q1 29,693,376 $237,250,217 -$9,782,816 $7.99 29
2022 Q4 30,892,511 $299,454,602 -$7,759,406 $9.72 32
2022 Q3 31,599,032 $367,179,200 -$9,454,337 $11.62 33
2022 Q2 32,559,951 $324,989,656 +$3,737,200 $9.98 33
2022 Q1 32,084,312 $586,822,000 +$37,199,278 $18.29 30
2021 Q4 30,046,921 $700,993,000 +$26,953,821 $23.33 29
2021 Q3 28,509,902 $625,158,000 +$21,272,275 $22.06 29
2021 Q2 27,592,126 $593,693,000 +$593,693,000 $21.73 34
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .